Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07750210
What this trial is testing

Study of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults With Type 1 Diabetes

Who this might be right for
MASLDType 1 Diabetes
Sohag University 250
Not applicableStudy completedNCT00533910
What this trial is testing

Rifaximin in Minimal Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
Hunter Holmes Mcguire Veteran Affairs Medical Center 42
Testing effectiveness (Phase 2)Study completedNCT00869713
What this trial is testing

Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated

Who this might be right for
Rift Valley Fever
U.S. Army Medical Research and Development Command 98
Post-approval studies (Phase 4)Study completedNCT02938013
What this trial is testing

DeLIVER: Direct Acting Antiviral Effects on the Liver

Who this might be right for
HCV CoinfectionLiver DiseaseHIV
Johns Hopkins University 15
Early research (Phase 1)Study completedNCT01217359
What this trial is testing

Differences in Evoked Intracellular Interferon Signaling Pathways Using Single Cell Phosphoprotein Profiling

Who this might be right for
Hepatitis C
University of North Carolina, Chapel Hill 22
Not applicableStudy completedNCT00941876
What this trial is testing

Integration of Family Planning and HIV Services in Tanzania

Who this might be right for
HIV InfectionHIV Infections
FHI 360 864
Early research (Phase 1)Ended earlyNCT03685591
What this trial is testing

PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

Who this might be right for
Breast NeoplasmsProstate NeoplasmsNeoplasms, Squamous Cell+6 more
Pfizer 49
Post-approval studies (Phase 4)Study completedNCT00353418
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 415
Testing effectiveness (Phase 2)UnknownNCT01724697
What this trial is testing

Safety and Efficacy of Human Bone Marrow Stem Cells for Treatment of HBV-related Liver Cirrhosis

Who this might be right for
Liver CirrhosisEnd Stage Liver Disease
Air Force Military Medical University, China 240
Post-approval studies (Phase 4)WithdrawnNCT03381859
What this trial is testing

Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy of
University of Maryland, Baltimore
Testing effectiveness (Phase 2)Study completedNCT03712280
What this trial is testing

MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)

Who this might be right for
Hepatic CirrhosisHepatic Encephalopathy (HE)
Mallinckrodt 50
Not applicableStudy completedNCT00476879
What this trial is testing

Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content

Who this might be right for
MetabolismFatty Liver
University of Aarhus 10
Post-approval studies (Phase 4)Study completedNCT00474955
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 27
Early research (Phase 1)Active Not RecruitingNCT06005740
What this trial is testing

A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer

Who this might be right for
Advanced Solid TumorHepatocellular Carcinoma
TORL Biotherapeutics, LLC 70
Early research (Phase 1)Study completedNCT01134718
What this trial is testing

TMC435-TiDP16-C119 - A Study Comparing 2 New Capsule Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Respective Blood Levels of TMC435 Following Single Dose Administration

Who this might be right for
Hepatitis C Virus
Tibotec Pharmaceuticals, Ireland 24
Large-scale testing (Phase 3)Not Yet RecruitingNCT07309380
What this trial is testing

Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D

Who this might be right for
Hepatitis D, Chronic
Shanghai HEP Pharmaceutical Co., Ltd. 150
Post-approval studies (Phase 4)Study completedNCT00862446
What this trial is testing

Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver Disease

Who this might be right for
Parenteral Nutrition Associated Liver Disease
Vanderbilt University Medical Center 48
Not applicableStudy completedNCT04675125
What this trial is testing

A Prospective Study of Application of Platelet Mapping in Chronic Liver Disease Complicated With ALI and/or AD in China

Who this might be right for
Thrombelastography, Acute Liver Injury, Acute Decompensation, Platelet
Nanfang Hospital, Southern Medical University 200
Post-approval studies (Phase 4)UnknownNCT05920213
What this trial is testing

Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy Stage 2Hepatic Encephalopathy Stage 3Hepatic Encephalopathy Stage 4
Jinnah Postgraduate Medical Centre 360
Testing effectiveness (Phase 2)UnknownNCT06482008
What this trial is testing

HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II Study

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 33
Next Page